Economics ❯ Healthcare Economics ❯ Drug Costs
Price Regulation Consumer Behavior Price Comparison Biosimilar Market Consumer Impact Supply Chain Issues
Most Americans are unlikely to see lower out-of-pocket costs despite MFN promises.
